Origin of pain in migraine: evidence for peripheral sensitisation

The Lancet Neurology

Volumn 8, Issue 7, 2009, Pages 679-690

  Olesen, Jes ^a   Burstein, Rami ^b   Ashina, Messoud ^a   Tfelt Hansen, Peer ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ARTERY; HUMAN; MIGRAINE; MIGRAINE AURA; NERVE CELL; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFERRED PAIN;

EID: 67649598903     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70090-0     Document Type: Note

References (140)

1. In: Olesen J., Goadsby P.J., Ramadan N., Tfelt-Hansen P., and Welch K. (Eds). The Headaches. 3rd edn. (2006), Lippincott, Williams and Wilkins, Philadelphia 1-1169
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, 2nd edn. Cephalalgia 24 suppl 1 (2004) 9-160
3. Olesen J., Larsen B., and Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9 (1981) 344-352
4. Olesen J., Friberg L., Olsen T.S., et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28 (1990) 791-798
5. Hadjikhani N., Del Rio M.S., et al. Mechanism of migraine aura revealed by functional MRI in the visual cortex. Proc Natl Acad Sci USA 98 (2001) 4687-4692
6. Moskowitz M.A. The neurobiology of vascular head pain. Ann Neurol 16 (1984) 157-168
7. Moskowitz M.A. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41 (1991) 182-186
8. Moskowitz M.A. The 2006 Thomas Willis lecture: the adventure of a translational researcher in stroke and migraine. Stroke 38 (2007) 1645-1651
9. Levy D., Jakubowski M., and Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons by a 5HT1B/1D receptor agonist: implications for migraine therapy with triptans. Proc Nat Acad Sci USA 101 (2004) 4274-4279
10. Strassman A.M., Raymond S.A., and Burstein R. Sensitization of meningeal sensory neurons and the origin of headache. Nature 384 (1996) 560-564
11. Burstein R., Yamamura H., Malick A., and Strassman A.M. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79 (1998) 964-982
12. Goadsby P.J. Migraine pathophysiology. Headache 45 suppl 1 (2005) S14-S24
13. Goadsby P.J. Recent advances in understanding migraine mechanism, molecules and therapeutics. Trends Mol Med 13 (2007) 39-44
14. Lassen L.H., Thomsen L.L., and Olesen J. Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 15 (1995) 1475-1479
15. Olesen J., Iversen H.K., and Thomsen L.L. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4 (1993) 1027-1030
16. Olesen J., Thomsen L.L., and Iversen H. Nitric oxide is a key molecule in migraine and other vascular headache. Trends Pharmacol Sci 15 (1994) 149-153
17. Lassen L.H., Haderslev P.A., Jacobsen V.B., Iversen H.K., Sperling B., and Olesen J. CGRP may play a causative role in migraine. Cephalalgia 22 (2002) 54-61
18. Schytz H.W., Birk S., Wienecke T., Kruuse C., Olesen J., and Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132 (2009) 16-25
19. Burstein R., Yarnitsky D., Goor-Arveh I., Ransil B.J., and Bajwa Z.H. An association between migraine and cutaneous allodynia. Ann Neurol 47 (2000) 614-624
20. Burstein R., Collins B., and Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55 (2004) 19-26
21. Humphrey P.P. The discovery of a new drug class for the acute treatment of migraine. Headache 47 suppl 1 (2007) S10-S19
22. Tfelt-Hansen P., De Vries P., and Saxena P.R. Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60 (2000) 1259-1287
23. Olesen J., Diener H.-C., Husstedt I.W., et al., the BIBN 4096 BS Clinical Proof of Concept Sudy Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350 (2004) 1104-1110
24. Ho T.W., Mannix L.K., Fan X., et al. Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70 (2008) 1304-1312
25. Penfield W., and McNaughton F. Dural headache and innervation of the dura mater. Arch Neurol Psychiatry 44 (1940) 43-75
26. Wolff H.G. Headache and other head pain. 2nd edn. (1963), Oxford University Press: Oxford, Oxford
27. Edvinsson L., and Abel M. Anatomy of muscles, tendons, joints, blood vessels and meninges. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The Headaches. 3rd edn. (2006), Lippincott Williams & Wilkins, Philadelphia, USA 71-93
28. Messlinger K., Strassman A M., and Burstein R. Anatomy and physiology of pain-sensitive cranial structures. In: Silberstein S., Goadsby P.G., and Dodick D. (Eds). Wolff's headache and other head pains. 8th edn. (2007), Oxford University Press, New York
29. Messlinger K., Dostrovsky J.O., and Strassmann A.M. Anatomy and physiology of head pain. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The headaches. 3rd edn. (2006), Lippincott Williams & Wilkins, Philadelphia 95-109
30. Burstein R., Levy D., Jakubowski M., and Woolf C.J. Peripheral and central sensitization related to headache. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The headaches. 3rd edn. (2006), Lippincott Williams & Wilkins, Philadelphia 119-126
31. Dubner R., Sessle B.J., and Storey A.T. The neural basis of oral and facial function (1978), Plenum, New York
32. Hinsey J.C. Observations on the innervation of blood vessels in skeletal muscles. J Comp Neurol 47 (1928) 23-65
33. Jensen K. Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta Neurol Scand Suppl 147 (1993) 1-27
34. Svensson P., and Ashina M. Human studies of experimental pain from muscle. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The Headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia 627-635
35. Ray B.S., and Wolff H.G. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg 41 (1940) 813-856
36. Nichols III F.T., Mawad M., Mohr J.P., Stein B., Hilal S., and Michelsen W.I. Focal headache during balloon inflation in the internal and middle cerebral artery. Stroke 21 (1990) 555-559
37. Price D.D., McHahhie J.G., and Larson M.A. Spatial summation of heat-induced pain: influence of stimulus area and spatial separation of stimuli on perceived pain sensation intensity and unpleasantness. J Neurophysiol 62 (1989) 1270-1279
38. Staud R., Koo E., Robinson M.E., and Price D.D. Spatial summation of mechanically evoked muscle pain and painful after sensations in normal subjects and fibromyalgia patients. Pain 130 (2007) 177-187
39. Cherry-Croze S., and Duclaux R. Discrimination of painful stimuli in human beings: influence of stimulation area. J Neurophysiol 44 (1980) 1-10
40. Andres K.H., von During M., Muszynski K., and Schmidt R.F. Nerve fibres and their terminals of the dura mater encephali of the rat. Anat Embryol 175 (1987) 289-301
41. Jansen-Olesen I., Jørgensen L., Engel U., and Edvinsson L. In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 481 (2003) 207-216
42. Yamamura H., Malick A., Chamberlin N.L., and Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 81 (1999) 479-493
43. Bahra A., Matharu M.S., Buchel C., Frackowiak R.S., and Goadsby P.J. Brainstem activation specific to migraine headache. Lancet 357 (2001) 1016-1017
44. Weiller C., May A., Limmroth V., et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1 (1995) 658-660
45. Raskin N.H., Hosobuchi Y., and Lamb S. Headache may arise from perturbation of brain. Headache 27 (1987) 416-420
46. Harner S.G., Beatty C.W., and Ebersold M.J. Headache after acoustic neuroma excision. Am J Otol 14 (1993) 552-555
47. Schaller B., and Baumann A. Headache after removal of vestibular schwannoma via the retrosigmoid approach: a long-term follow-up-study. Otolaryngol Head Neck Surg 128 (2003) 387-395
48. Gokalp H.Z., Arasil E., Erdogan A., Egemen N., Deda H., and Cerci A. Tentorial meningiomas. Neurosurgery 36 (1995) 46-51
49. Kaur A., Selwa L., Fromes G., and Ross D.A. Persistent headache after supratentorial craniotomy. Neurosurgery 47 (2000) 633-636
50. Gee J.R., Ishaq Y., and Vijayan N. Postcraniotomy headache. Headache 43 (2003) 276-278
51. Derbyshire S.W., Jones A.K., Creed F., et al. Cerebral responses to noxious thermal stimulation in chronic low back pain patients and normal controls. Neuroimage 16 (2002) 158-168
52. Hsieh J.C., Stahle-Backdahl M., Hagermark O., Stone-Elander S., Rosenquist G., and Ingvar M. Traumatic nociceptive pain activates the hypothalamus and the periaqueductal gray: a positron emission tomography study. Pain 64 (1996) 303-314
53. Iadarola M.J., Berman K.F., Zeffiro T.A., et al. Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain 121 (1998) 931-947
54. Petrovic P., Ingvar M., Stone-Elander S., Petersson K.M., and Hansson P. A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy. Pain 83 (1999) 459-470
55. Keay K.A., Li Q.F., and Bandler R. Muscle pain activates a direct periaquaductal gray to rostral ventrolateral medulla in rats. Neurosci Lett 290 (2000) 157-160
56. Basbaum A.I., Clanton C.H., and Fields H.L. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol 178 (1978) 209-224
57. Fields H.L., Malick A., and Burstein R. Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol 74 (1995) 1742-1759
58. Holstege G., and Kuypers H.G. The anatomy of brain stem pathways to the spinal cord in cat. A labeled amino acid tracing study. Prog Brain Res 57 (1982) 145-175
59. Martin G.F., Vertes R.P., and Waltzer R. Spinal projections of the gigantocellular reticular formation in the rat. Evidence for projections from different areas to laminae I and II and lamina IX. Exp Brain Res 58 (1985) 154-162
60. Knight Y.E., and Goadsby P.J. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?. Neuroscience 106 (2001) 793-800
61. Knight Y.E., Bartsch T., Kaube H., and Goadsby P.J. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?. J Neurosci 22 (2002) RC213
62. Bartsch T., Knight Y.E., and Goadsby P.J. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 56 (2004) 371-381
63. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci 25 (2002) 319-325
64. Haas D.C., Kent P.F., and Friedman D.I. Headache caused by a single lesion of multiple-sclerosis in the periaqueductal gray area. Headache 33 (1993) 452-455
65. Afridi S., and Goadsby P.J. New onset migraine with a brain stem cavernous angioma. J Neurol Neurosurg Psychiatry 74 (2003) 680-682
66. Goadsby P.J. Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 22 (2002) 107-111
67. Katsarava Z., Egelhof T., Kaube H., Diener H.C., and Limmroth V. Symptomatic migraine and sensitization of trigeminal nociception associated with contralateral pontine cavernoma. Pain 105 (2003) 381-384
68. Lipton R.B., Bigal M.E., Ashina S., et al. Cutaneous allodynia in the migraine population. Ann Neurol 63 (2007) 148-158
69. Daugaard D., Thomsen L.L., and Olesen J. No relation between cephalic venous dilatation and pain in migraine. J Neurol Neurosurg Psychiatry 65 (1998) 260-262
70. Doepp F., Schreiber S.J., Dreier J.P., Einhäupl K.M., and Valduza J.M. Migraine aggravation by cephalic venous congestion. Headache 43 (2003) 96-98
71. Chou C.H., Chao A.C., Lu S.P., Hu H.H., and Wang S.J. Cephalic venous congestion aggravates only migraine-like type headaches. Cephalalgia 24 (2004) 973-979
72. Heyck H. Neue Beiträge zur Klinik und Pathogenese der Migräne (1956), Thieme Verlag, Stuttgart
73. Friedman A.P. Current concepts in the diagnosis and treatment of chronic recurring headache. Med Clin North Am 56 (1972) 1257-1271
74. Dimitriadou V., Buzzi M.G., Theoharides T.L., and Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dural mater and tongue following antidromic trigeminal stimulation. Neuroscience 48 (1992) 187-203
75. Drummond P.D., and Lance J.W. Extravascular changes and the source of pain in migraine headache. Ann Neurol 13 (1983) 32-37
76. Ducros A., Boukobza M., Porcher R., Sarov M., Valade D., and Bousser M.G. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130 (2007) 3091-3101
77. Tfelt-Hansen P., Lous I., and Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache 21 (1981) 49-54
78. Iversen H.K., Nielsen T.H., Olesen J., and Tfelt-Hansen P. Arterial responses during migraine headaches. Lancet 336 (1990) 837-839
79. Blau J.N., and Dexter S.L. The site of pain origin during migraine attacks. Cephalalgia 1 (1981) 143-147
80. Iversen H.K., Olesen J., and Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38 (1989) 17-24
81. Petersen K.A., Lassen L.H., Birk S., Lesko L., and Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene-related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77 (2005) 202-213
82. Dalsgaard-Nielsen T. Migraine diagnostics with special reference to pharmacological tests. Int Arch Allergy 7 (1955) 312-322
83. Hansen H.J., and Drewes V.M. The nitroglycerine ointment test-a double-blind examination. Dan Med Bull 17 (1970) 226-229
84. Berner B., and John V.A. Pharmacokinetic characterisation of transdermal delivery systems. Clin Pharmacokin 26 (1994) 121-134
85. Christiansen I., Iversen H.K., Olesen J., and Tfelt-Hansen P. Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide 5-mononitrate. J Headache Pain 9 (2008) 215-220
86. Kruuse C., Thomsen L.L., Birk S., and Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126 (2003) 241-247
87. Hansen J.M., Sitarz J., Birk S., et al. Vasoactive intestinal polypeptide evokes only minimal headache in healthy volunteers. Cephalalgia 26 (2006) 992-1003
88. Petersen K.A., Birk S., Kitamura K., and Olesen J. Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders. Cephalalgia 29 (2009) 23-30
89. May A., Gijsman H.J., Wallnöfer A., Jones R., Diener H.C., and Ferrari M.D. Endothelin antagonist bosentan blocks inflammation, but is not effective in aborting migraine attacks. Pain 67 (1996) 375-378
90. Goldstein D.J., Offen W.W., Klein E.G., et al. Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 21 (2001) 102-106
91. Goldstein D.J., Wang O., Saper J.R., Stoltz R., Silberstein S.D., and Mathew N.T. Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17 (1997) 785-790
92. Levy D., and Strassman A.M. Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol 88 (2003) 3021-3031
93. Burstein R., Cutrer M.F., and Yamitsky D. The development of cutaneous allodynia during migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123 (2000) 1703-1709
94. Petersen K.A., Dyrby L., Williamson D., Edvinsson L., and Olesen J. Effect of hypotension and carbon dioxide changes in an improved genuine closed cranial window model. Cephalalgia 25 (2005) 23-29
95. Jansen I., Edvinsson L., Mortensen A., and Olesen J. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia 12 (1992) 202-205
96. Jansen I., Olesen J., and Edvinsson L. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 147 (1993) 141-150
97. Petersen K.A., Birk S., Doods H., Edvinsson L., and Olesen J. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP and transcranial electrical stimulation in the rat. Br J Pharmacol 143 (2004) 697-704
98. Gozalov A., Jansen-Olesen I., Klaerke D., and Olesen J. Role of BK(Ca) channels in cephalic vasodilatation induced by CGRP, NO and transcranial electrical stimulation in the rat. Cephalalgia 27 (2007) 1120-1127
99. Levy D., Burstein R., Kainz V., Jakubowski M., and Strassman A.M. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130 (2007) 166-176
100. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 (2002) 136-142
101. Schoonman G.G., van der Grond J., Kortmann C., van der Geest R.J., Terwindt G.M., and Ferrari M.D. Migraine headache is not associated with cerebral or meningeal vasodilatation-a 3T magnetic resonance angiographic study. Brain 131 (2008) 2192-2200
102. Strassman A.M., and Levy D. Response properties of dural noniceptors in relation to headache. J Neurophysiol 95 (2006) 1298-1306
103. Lauritzen M. Cortical spreading depression as a putative migraine mechanism. Trends Neurosci 10 (1987) 8-13
104. Lauritzen M. Pathophysiology of migraine aura. The spreading depression theory. Brain 117 (1994) 199-210
105. Fabricius M., Fuhr S., Willumsen L., et al. Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain. Clin Neurophysiol 119 (2008) 1973-1984
106. Dohmen C., Sakowitz O.W., Fabricius M., et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol 63 (2008) 720-728
107. Fabricius M., Fuhr S., Bhatia R., et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 129 (2006) 778-790
108. Strong A.J., Fabricius M., Boutelle M.G., et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 33 (2002) 2738-2743
109. Lauritzen M., and Kraig R.P. Spreading depression. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The Headaches. 3rd edn. (2006), Lippincott, Williams & Wilkins, Philadelphia 269-274
110. Moskowitz M.A., Nozahi K., and Kraig R.P. Neocortical depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13 (1993) 1167-1177
111. Gursoy-Ozdemir Y., Qui J., Matsuoko N., et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113 (2004) 1447-1455
112. Graham J.R., and Wolff H.G. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39 (1938) 737-763
113. Iversen H.K., and Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16 (1996) 412-418
114. Razzaque Z., Pickard J.D., Ma Q.P., et al. 5-HT1B receptors and vascular reactivity in human isolated blood vessels: assessement of the potential cardiovascular selectivity of sumatriptan. Br J Clin Pharmacol 53 (2002) 266-274
115. Cameron M. Chronic subdural hematoma: a review of 114 cases. J Neurol Neurosurg Psychiatry 41 (1978) 834-839
116. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 46 suppl 3 (1993) S16-S20
117. Levy D., Burstein R., and Strassman A.M. Mast cell involvement in the pathogenesis of migraine headache: a hypothesis. Headache 46 suppl 1 (2006) S13-S18
118. Levy D., Burstein R., and Strassman A.M. Calcitonin gene-related peptide does not excite or sensitize meningeal receptors: implications for the pathophysiology of migraine. Ann Neurol 58 (2005) 698-705
119. del Rio M.S., Bakker D., Wu O., et al. Perfusion-weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 19 (1999) 701-708
120. Vaidhyanath R., Kenningham R., Kahn A., and Messois N. Spontaneous intracranial hypotension as a cause of severe acute headache. Emerg Med J 24 (2007) 739-741
121. Limmroth V., May A., Auerbach P., Wosnitza G., Eppe T., and Diener H.C. Changes in cerebral blood flow velocities after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci 138 (2004) 60-65
122. Bruyn G.W. Intracranial arteriovenous malformation and migraine. Cephalalgia 4 (1984) 191-207
123. Oestergaard J.R., and Ramadan N.M. Unruptured vascular malformation and subarachnoidal hemorrhage. In: Olesen J., Goadsby P.J., Ramadan N.M., Tfelt-Hansen P., and Welch K. (Eds). The headaches. 3rd edn. (2006), Lippincott, Williams & Wilkins, Philadelphia 469-503
124. Humphrey P.P., Feniuk W., Perren M.J., Beresford I.J., Skingle M., and Whalley E.T. Serotonin and migraine. Ann N Y Acad Sci 600 (1990) 587-598
125. Schmetterer L., Wolzt M., Krejcy K., et al. Cerebral and occular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin Pharmacol Ther 60 (1996) 199-205
126. Thomaides T., Karagounakis D., Spantideas A., and Katelanis S. Transcranial doppler in migraine attacks before and after treatment with oral zolmitriptan and sumatriptan. Headache 43 (2003) 54-58
127. Friberg L., Olesen J., Iversen H.K., and Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 338 (1991) 13-17
128. Thomsen L.L., Iversen H.K., Brinck T.A., and Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 23 (1993) 395-399
129. Ottosson A., Jansen I., and Edvinsson L. Characterization of histamine receptors in isolated human cerebral arteries. Br J Pharmacol 94 (1988) 901-907
130. Ottosson A., Jansen I., and Edvinsson L. Characterization of histamine receptors in the human temporal artery. Br J Clin Pharmacol 27 (1989) 139-145
131. Christiansen I., Thomsen L.L., Daugaard D., Ulrich V., and Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 19 (1999) 660-667
132. Burstein R., and Jakubowski M. A unitary hypothesis for multiple triggers of the pain and strain of migraine. J Com Neurol 493 (2005) 9-14
133. Gupta R., and Bhatia M.S. A report of cranial autonomic symptoms in migraineurs. Cephalalgia 27 (2007) 22-28
134. Toda N., Tanaka T., Ayajiki K., and Okamura T. Cerebral vasodilatation induced by stimulation of the pterygopalatine ganglion and greater petrosal nerve in anesthetized monkeys. Neuroscience 96 (2000) 393-398
135. Toda N., and Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55 (2003) 271-324
136. Day M. Sphenopalatine ganglion analgesia. Curr Rev Pain 3 (1999) 342-347
137. Maizels M., and Geiger A.M. Intranasal lidocaine for migraine: a randomized trial and open-labeled follow-up. Headache 39 (1999) 543-551
138. Maizels M., Scott B., Cohen W., and Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 276 (1996) 319-321
139. Blanda M., Rench T., Gerson L.W., and Weigard J.V. Intranasal lidocaine for treatment of migraine attacks: a randomized, controlled trial. Acad Emerg Med 8 (2001) 337-342
140. Yarnitsky D., Goor-Aryeh I., Sutile A., et al. Parasympathetic contributions to peripheral and central sensitization during migraine. Headache 43 (2003) 1-11